+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Anergis SA - logo

Anergis SA is a clinical-stage biopharmaceutical company that develops allergy vaccines based on the technology of Contiguous Overlapping Peptides for ultra-fast desensitization. It offers vaccines against birch pollen, ragweed pollen, and house dust mite allergies. Anergis SA was founded in 2001 and is based in Lausanne, Switzerland.

Allergy Immunotherapy Global Market Report 2024 - Product Thumbnail Image

Allergy Immunotherapy Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Allergy Immunotherapy Market Report and Forecast 2024-2032 - Product Thumbnail Image

Allergy Immunotherapy Market Report and Forecast 2024-2032

  • Report
  • July 2024
  • 200 Pages
  • Global
From
From
Birch Pollen Allergy - Pipeline Insight, 2024 - Product Thumbnail Image

Birch Pollen Allergy - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Ragweed Pollen Allergy - Pipeline Review, H2 2020 - Product Thumbnail Image

Ragweed Pollen Allergy - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 35 Pages
  • Global
From
From
Immunology Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Immunology Collaboration and Licensing Deals 2016-2024

  • Report
  • October 2024
  • 450 Pages
  • Global
From
From
Ragweed pollen hypersensitivity - Pipeline Insight, 2024 - Product Thumbnail Image

Ragweed pollen hypersensitivity - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 40 Pages
  • Global
From
  • 16 Results (Page 1 of 1)
Loading Indicator